4//SEC Filing
Aggarwal Sumit 4
Accession 0001415889-21-002554
CIK 0001035354other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:45 PM ET
Size
6.2 KB
Accession
0001415889-21-002554
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Award
Stock Options (Right to Buy)
2021-05-18+992,409→ 992,409 totalExercise: $1.41Exp: 2031-04-01→ Common Stock (992,409 underlying)
Footnotes (1)
- [F1]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan in accordance with the anti-dilution provisions of the Reporting Person's employment agreement in connection with a Qualifying Financing as defined therein. The stock options vest and become exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter, subject to Reporting Person's continued employment or other service with the Issuer on each applicable vesting date, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001854362
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:45 PM ET
- Size
- 6.2 KB